The Oncology Institute, Inc.TOINASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank71
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-5.80%
↑ 43% vs avg
Percentile
P71
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-10.19%
Historical baseline
PeriodValueYoY Change
TTM-5.80%+57.6%
2024-13.68%+18.3%
2023-16.74%+37.5%
2022-26.77%-29.3%
2021-20.71%-244.0%
2020-6.02%-3146.7%
20190.20%-97.5%
20188.02%-